Cartesian Therapeutics Financial Overview
Cartesian Therapeutics's market cap is currently $204.13M. The company's EPS TTM is $-1.38; its P/E ratio is ―; Cartesian Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
